nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—migraine—Prednisone—multiple sclerosis	0.536	1	CpDpCtD
Antipyrine—CYP2E1—Fingolimod—multiple sclerosis	0.0513	0.134	CbGbCtD
Antipyrine—PTGS2—Triamcinolone—multiple sclerosis	0.0384	0.1	CbGbCtD
Antipyrine—PTGS2—Betamethasone—multiple sclerosis	0.0329	0.086	CbGbCtD
Antipyrine—CYP2A6—Prednisolone—multiple sclerosis	0.0321	0.0839	CbGbCtD
Antipyrine—CYP2D6—Fingolimod—multiple sclerosis	0.0244	0.0638	CbGbCtD
Antipyrine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0241	0.0629	CbGbCtD
Antipyrine—PTGS2—Dexamethasone—multiple sclerosis	0.0192	0.05	CbGbCtD
Antipyrine—CYP2A6—Dexamethasone—multiple sclerosis	0.0189	0.0494	CbGbCtD
Antipyrine—TRPA1—trigeminal nerve—multiple sclerosis	0.0178	0.387	CbGeAlD
Antipyrine—CYP3A4—Fingolimod—multiple sclerosis	0.0155	0.0406	CbGbCtD
Antipyrine—CYP2C19—Prednisone—multiple sclerosis	0.0125	0.0328	CbGbCtD
Antipyrine—CYP2E1—Dexamethasone—multiple sclerosis	0.0125	0.0326	CbGbCtD
Antipyrine—CYP2B6—Dexamethasone—multiple sclerosis	0.0123	0.0322	CbGbCtD
Antipyrine—SLC22A6—Methotrexate—multiple sclerosis	0.0114	0.0298	CbGbCtD
Antipyrine—CYP3A4—Methylprednisolone—multiple sclerosis	0.01	0.0261	CbGbCtD
Antipyrine—CYP2C8—Dexamethasone—multiple sclerosis	0.00933	0.0244	CbGbCtD
Antipyrine—TRPA1—peripheral nervous system—multiple sclerosis	0.00836	0.181	CbGeAlD
Antipyrine—CYP2C19—Dexamethasone—multiple sclerosis	0.00783	0.0205	CbGbCtD
Antipyrine—CYP3A4—Triamcinolone—multiple sclerosis	0.00759	0.0198	CbGbCtD
Antipyrine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0073	0.0191	CbGbCtD
Antipyrine—TRPA1—nerve—multiple sclerosis	0.00652	0.141	CbGeAlD
Antipyrine—CYP2C9—Dexamethasone—multiple sclerosis	0.00651	0.017	CbGbCtD
Antipyrine—CYP3A4—Betamethasone—multiple sclerosis	0.00651	0.017	CbGbCtD
Antipyrine—CYP3A4—Prednisolone—multiple sclerosis	0.00642	0.0168	CbGbCtD
Antipyrine—CYP3A4—Prednisone—multiple sclerosis	0.00606	0.0158	CbGbCtD
Antipyrine—CYP2D6—Dexamethasone—multiple sclerosis	0.00595	0.0155	CbGbCtD
Antipyrine—CYP3A4—Dexamethasone—multiple sclerosis	0.00379	0.00989	CbGbCtD
Antipyrine—TRPA1—spinal cord—multiple sclerosis	0.00174	0.0377	CbGeAlD
Antipyrine—PTGS2—leg—multiple sclerosis	0.00167	0.0362	CbGeAlD
Antipyrine—TRPA1—nervous system—multiple sclerosis	0.00147	0.0318	CbGeAlD
Antipyrine—TRPA1—central nervous system—multiple sclerosis	0.00141	0.0306	CbGeAlD
Antipyrine—SLC22A6—brain—multiple sclerosis	0.000459	0.00996	CbGeAlD
Antipyrine—CYP2A6—cerebellum—multiple sclerosis	0.000441	0.00957	CbGeAlD
Antipyrine—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000413	0.159	CbGdCrCtD
Antipyrine—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000407	0.156	CbGdCrCtD
Antipyrine—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000407	0.156	CbGdCrCtD
Antipyrine—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000398	0.153	CbGdCrCtD
Antipyrine—CYP2A6—brain—multiple sclerosis	0.000359	0.00777	CbGeAlD
Antipyrine—CYP2D6—brainstem—multiple sclerosis	0.000335	0.00726	CbGeAlD
Antipyrine—CYP2E1—medulla oblongata—multiple sclerosis	0.000295	0.00639	CbGeAlD
Antipyrine—PTGS2—medulla oblongata—multiple sclerosis	0.000272	0.00589	CbGeAlD
Antipyrine—CYP2E1—spinal cord—multiple sclerosis	0.000263	0.0057	CbGeAlD
Antipyrine—PTGS1—spinal cord—multiple sclerosis	0.000253	0.00549	CbGeAlD
Antipyrine—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000249	0.0958	CbGdCrCtD
Antipyrine—PTGS2—midbrain—multiple sclerosis	0.000248	0.00538	CbGeAlD
Antipyrine—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000246	0.0943	CbGdCrCtD
Antipyrine—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000246	0.0943	CbGdCrCtD
Antipyrine—PTGS2—spinal cord—multiple sclerosis	0.000242	0.00525	CbGeAlD
Antipyrine—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00024	0.0921	CbGdCrCtD
Antipyrine—CYP2B6—nervous system—multiple sclerosis	0.000236	0.00512	CbGeAlD
Antipyrine—CYP2B6—central nervous system—multiple sclerosis	0.000227	0.00493	CbGeAlD
Antipyrine—CYP2E1—nervous system—multiple sclerosis	0.000222	0.0048	CbGeAlD
Antipyrine—PTGS1—nervous system—multiple sclerosis	0.000214	0.00463	CbGeAlD
Antipyrine—CYP2E1—central nervous system—multiple sclerosis	0.000213	0.00462	CbGeAlD
Antipyrine—CYP2E1—cerebellum—multiple sclerosis	0.000209	0.00452	CbGeAlD
Antipyrine—PTGS1—central nervous system—multiple sclerosis	0.000206	0.00445	CbGeAlD
Antipyrine—PTGS2—nervous system—multiple sclerosis	0.000204	0.00442	CbGeAlD
Antipyrine—CYP2C8—brain—multiple sclerosis	0.000201	0.00436	CbGeAlD
Antipyrine—PTGS2—central nervous system—multiple sclerosis	0.000197	0.00426	CbGeAlD
Antipyrine—PTGS2—cerebellum—multiple sclerosis	0.000192	0.00416	CbGeAlD
Antipyrine—CYP2B6—brain—multiple sclerosis	0.000181	0.00391	CbGeAlD
Antipyrine—CYP3A4—nervous system—multiple sclerosis	0.000178	0.00386	CbGeAlD
Antipyrine—CYP2D6—nervous system—multiple sclerosis	0.000176	0.0038	CbGeAlD
Antipyrine—CYP3A4—central nervous system—multiple sclerosis	0.000172	0.00372	CbGeAlD
Antipyrine—CYP2E1—brain—multiple sclerosis	0.000169	0.00367	CbGeAlD
Antipyrine—CYP2D6—central nervous system—multiple sclerosis	0.000169	0.00366	CbGeAlD
Antipyrine—CYP2D6—cerebellum—multiple sclerosis	0.000165	0.00358	CbGeAlD
Antipyrine—PTGS1—brain—multiple sclerosis	0.000163	0.00354	CbGeAlD
Antipyrine—PTGS2—brain—multiple sclerosis	0.000156	0.00338	CbGeAlD
Antipyrine—CYP2D6—brain—multiple sclerosis	0.000134	0.00291	CbGeAlD
Antipyrine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.51e-05	0.0017	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	5.5e-05	0.00169	CbGpPWpGaD
Antipyrine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.49e-05	0.00169	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	5.48e-05	0.00169	CbGpPWpGaD
Antipyrine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.37e-05	0.00166	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.29e-05	0.00163	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.29e-05	0.00163	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—SRM—multiple sclerosis	5.19e-05	0.0016	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	5.18e-05	0.0016	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.06e-05	0.00156	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	4.93e-05	0.00152	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	4.88e-05	0.00151	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	4.83e-05	0.00149	CbGpPWpGaD
Antipyrine—CYP2C18—Biological oxidations—POMC—multiple sclerosis	4.81e-05	0.00148	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.77e-05	0.00147	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.77e-05	0.00147	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.71e-05	0.00145	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.71e-05	0.00145	CbGpPWpGaD
Antipyrine—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.65e-05	0.00143	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	4.6e-05	0.00142	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	4.57e-05	0.00141	CbGpPWpGaD
Antipyrine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.45e-05	0.00137	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	4.4e-05	0.00136	CbGpPWpGaD
Antipyrine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.36e-05	0.00134	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.2e-05	0.00129	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.2e-05	0.00129	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.17e-05	0.00129	CbGpPWpGaD
Antipyrine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.15e-05	0.00128	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	4.11e-05	0.00127	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.08e-05	0.00126	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4e-05	0.00123	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.99e-05	0.00123	CbGpPWpGaD
Antipyrine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	3.97e-05	0.00122	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.93e-05	0.00121	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	3.83e-05	0.00118	CbGpPWpGaD
Antipyrine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.81e-05	0.00118	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.8e-05	0.00117	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	3.79e-05	0.00117	CbGpPWpGaD
Antipyrine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.78e-05	0.00117	CbGpPWpGaD
Antipyrine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.77e-05	0.00116	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	3.65e-05	0.00113	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	3.65e-05	0.00113	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	3.63e-05	0.00112	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	3.56e-05	0.0011	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.54e-05	0.00109	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	3.5e-05	0.00108	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.5e-05	0.00108	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.42e-05	0.00105	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.42e-05	0.00105	CbGpPWpGaD
Antipyrine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.36e-05	0.00104	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.35e-05	0.00103	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—SRM—multiple sclerosis	3.34e-05	0.00103	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—GPC5—multiple sclerosis	3.34e-05	0.00103	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.32e-05	0.00102	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	3.25e-05	0.001	CbGpPWpGaD
Antipyrine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.23e-05	0.000996	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—SRM—multiple sclerosis	3.16e-05	0.000974	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	3.12e-05	0.000961	CbGpPWpGaD
Antipyrine—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.1e-05	0.000955	CbGpPWpGaD
Antipyrine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.09e-05	0.000953	CbGpPWpGaD
Antipyrine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.07e-05	0.000945	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.05e-05	0.00094	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.05e-05	0.00094	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.97e-05	0.000914	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.95e-05	0.000911	CbGpPWpGaD
Antipyrine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	2.93e-05	0.000903	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.87e-05	0.000884	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	2.85e-05	0.000879	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.78e-05	0.000857	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.78e-05	0.000857	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—RRM1—multiple sclerosis	2.77e-05	0.000854	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	2.77e-05	0.000852	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—SRM—multiple sclerosis	2.65e-05	0.000818	CbGpPWpGaD
Antipyrine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.62e-05	0.000807	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—SRM—multiple sclerosis	2.55e-05	0.000786	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	2.52e-05	0.000777	CbGpPWpGaD
Antipyrine—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.51e-05	0.000773	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—SRM—multiple sclerosis	2.5e-05	0.00077	CbGpPWpGaD
Antipyrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.49e-05	0.000769	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	2.47e-05	0.00076	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	2.46e-05	0.000757	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.38e-05	0.000732	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.38e-05	0.000732	CbGpPWpGaD
Antipyrine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	2.36e-05	0.000728	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.35e-05	0.000726	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.35e-05	0.000726	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	2.33e-05	0.000717	CbGpPWpGaD
Antipyrine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	2.31e-05	0.000713	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.31e-05	0.000712	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.3e-05	0.00071	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.3e-05	0.000709	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.3e-05	0.000709	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	2.26e-05	0.000698	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.26e-05	0.000697	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	2.23e-05	0.000686	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	2.23e-05	0.000686	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—SRM—multiple sclerosis	2.16e-05	0.000665	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GPC5—multiple sclerosis	2.15e-05	0.000664	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.15e-05	0.000663	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.15e-05	0.000663	CbGpPWpGaD
Antipyrine—PTGS2—Disease—GPC5—multiple sclerosis	2.04e-05	0.000629	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GPC5—multiple sclerosis	2.04e-05	0.000628	CbGpPWpGaD
Antipyrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.02e-05	0.000623	CbGpPWpGaD
Antipyrine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2e-05	0.000617	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—SRM—multiple sclerosis	1.93e-05	0.000594	CbGpPWpGaD
Antipyrine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	1.93e-05	0.000594	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.92e-05	0.000592	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.92e-05	0.000591	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.88e-05	0.000579	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.87e-05	0.000576	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.87e-05	0.000576	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.83e-05	0.000563	CbGpPWpGaD
Antipyrine—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.83e-05	0.000563	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.8e-05	0.000554	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.8e-05	0.000554	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.79e-05	0.000552	CbGpPWpGaD
Antipyrine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.79e-05	0.00055	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—RRM1—multiple sclerosis	1.78e-05	0.00055	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—SRM—multiple sclerosis	1.77e-05	0.000546	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000542	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000542	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.76e-05	0.000542	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GPC5—multiple sclerosis	1.71e-05	0.000527	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—RRM1—multiple sclerosis	1.69e-05	0.00052	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.64e-05	0.000507	CbGpPWpGaD
Antipyrine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.64e-05	0.000506	CbGpPWpGaD
Antipyrine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.63e-05	0.000502	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000496	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.00049	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.52e-05	0.000469	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.52e-05	0.000469	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—SRM—multiple sclerosis	1.5e-05	0.000463	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.49e-05	0.000458	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.44e-05	0.000445	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—RRM1—multiple sclerosis	1.42e-05	0.000437	CbGpPWpGaD
Antipyrine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.39e-05	0.000429	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.39e-05	0.000429	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.38e-05	0.000427	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.36e-05	0.00042	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.36e-05	0.000418	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.36e-05	0.000418	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000411	CbGpPWpGaD
Antipyrine—PTGS2—Disease—RPL5—multiple sclerosis	1.33e-05	0.000409	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.33e-05	0.000409	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.31e-05	0.000403	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.3e-05	0.000402	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.28e-05	0.000394	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.27e-05	0.000393	CbGpPWpGaD
Antipyrine—PTGS2—Disease—SLC11A1—multiple sclerosis	1.27e-05	0.000392	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.25e-05	0.000385	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.25e-05	0.000385	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.24e-05	0.000383	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.24e-05	0.000382	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.24e-05	0.000382	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.22e-05	0.000375	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.21e-05	0.000373	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.19e-05	0.000367	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.16e-05	0.000357	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.15e-05	0.000355	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.14e-05	0.000352	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.13e-05	0.000349	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.1e-05	0.000339	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.08e-05	0.000334	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.07e-05	0.000331	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.06e-05	0.000326	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.06e-05	0.000326	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.03e-05	0.000319	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.03e-05	0.000317	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—BCHE—multiple sclerosis	1.02e-05	0.000316	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD28—multiple sclerosis	1.02e-05	0.000313	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—BCHE—multiple sclerosis	9.69e-06	0.000299	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GPC5—multiple sclerosis	9.67e-06	0.000298	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—APOE—multiple sclerosis	9.57e-06	0.000295	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.46e-06	0.000292	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.44e-06	0.000291	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.38e-06	0.000289	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.94e-06	0.000276	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.61e-06	0.000265	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—POMC—multiple sclerosis	8.22e-06	0.000253	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.16e-06	0.000252	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.16e-06	0.000252	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—BCHE—multiple sclerosis	8.14e-06	0.000251	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—RRM1—multiple sclerosis	8.02e-06	0.000247	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.98e-06	0.000246	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—BCHE—multiple sclerosis	7.82e-06	0.000241	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.68e-06	0.000237	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—BCHE—multiple sclerosis	7.66e-06	0.000236	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—ALB—multiple sclerosis	7.49e-06	0.000231	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.47e-06	0.00023	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.28e-06	0.000224	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD86—multiple sclerosis	7.24e-06	0.000223	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7e-06	0.000216	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.86e-06	0.000211	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.62e-06	0.000204	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CCR5—multiple sclerosis	6.42e-06	0.000198	CbGpPWpGaD
Antipyrine—PTGS2—Disease—HLA-A—multiple sclerosis	6.26e-06	0.000193	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.25e-06	0.000193	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.25e-06	0.000193	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.22e-06	0.000192	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.19e-06	0.000191	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—APOE—multiple sclerosis	6.17e-06	0.00019	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.91e-06	0.000182	CbGpPWpGaD
Antipyrine—PTGS2—Disease—APOE—multiple sclerosis	5.84e-06	0.00018	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—APOE—multiple sclerosis	5.83e-06	0.00018	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.7e-06	0.000176	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.43e-06	0.000168	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.39e-06	0.000166	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.34e-06	0.000165	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—POMC—multiple sclerosis	5.3e-06	0.000163	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD80—multiple sclerosis	5.28e-06	0.000163	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—POMC—multiple sclerosis	5.01e-06	0.000154	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—APOE—multiple sclerosis	4.89e-06	0.000151	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.87e-06	0.00015	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ALB—multiple sclerosis	4.83e-06	0.000149	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—APOE—multiple sclerosis	4.7e-06	0.000145	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—APOE—multiple sclerosis	4.61e-06	0.000142	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—BCHE—multiple sclerosis	4.6e-06	0.000142	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ALB—multiple sclerosis	4.57e-06	0.000141	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TYK2—multiple sclerosis	4.46e-06	0.000138	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—POMC—multiple sclerosis	4.2e-06	0.00013	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—POMC—multiple sclerosis	4.04e-06	0.000125	CbGpPWpGaD
Antipyrine—PTGS2—Disease—CD4—multiple sclerosis	4.03e-06	0.000124	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—APOE—multiple sclerosis	3.98e-06	0.000123	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—POMC—multiple sclerosis	3.96e-06	0.000122	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ALB—multiple sclerosis	3.83e-06	0.000118	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ALB—multiple sclerosis	3.68e-06	0.000114	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ALB—multiple sclerosis	3.61e-06	0.000111	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—APOE—multiple sclerosis	3.55e-06	0.00011	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.55e-06	0.00011	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—POMC—multiple sclerosis	3.42e-06	0.000105	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.27e-06	0.000101	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.24e-06	9.99e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—STAT3—multiple sclerosis	3.12e-06	9.63e-05	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ALB—multiple sclerosis	3.12e-06	9.62e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—POMC—multiple sclerosis	3.05e-06	9.41e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MYC—multiple sclerosis	2.9e-06	8.95e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TGFB1—multiple sclerosis	2.9e-06	8.93e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MAPK1—multiple sclerosis	2.84e-06	8.75e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.81e-06	8.66e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.78e-06	8.58e-05	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ALB—multiple sclerosis	2.78e-06	8.58e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—APOE—multiple sclerosis	2.77e-06	8.54e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.56e-06	7.89e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.54e-06	7.83e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—POMC—multiple sclerosis	2.38e-06	7.33e-05	CbGpPWpGaD
Antipyrine—PTGS2—Disease—IL6—multiple sclerosis	2.18e-06	6.73e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ALB—multiple sclerosis	2.17e-06	6.69e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.14e-06	6.59e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.84e-06	5.66e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ALB—multiple sclerosis	1.67e-06	5.16e-05	CbGpPWpGaD
